Vacci-nation: A case study in health and prosperity
Article
Vaccines have been integral to health and prosperity in the last three centuries.
The Covid-19 vaccination has again demonstrated the value of vaccines – to lives, livelihoods, and national prosperity. Despite that success, it is imperative that the UK isn’t complacent: there is still huge room for improvement.
Doing better on vaccines could support population health, NHS system readiness and the economy. The key lesson from the Covid-19 vaccination programme is that an overly individualised approach to vaccine uptake and inequality is fundamentally limited.
On that basis, our policy recommendations explore how we can move ahead on vaccines, by harnessing the role of innovation, a wider range of public institutions, government, and businesses to support equality in access, uptake, and outcomes.
Related items

The loneliest generation: What it is like to grow up in England today
Connection should be the fabric that binds society together. But today’s young people have never felt more disconnected.
Bottleneck Britain: How digital competition could power UK growth and sovereignty
Artificial intelligence could be the UK’s biggest economic opportunity in a generation, but only if its gains are spread across the economy rather than pooled within a handful of companies.
Taxing times: Policies, politics, and principles
This paper sets out proposals for the path to a better tax system, which is able to meet the demands of both the public and a more dangerous world.